Newsfeeds - Spark Newswire

1 minute read

Oppenheimer Initiates Coverage On Blueprint Medicines with Outperform Rating, Announces Price Target of $80

Today, 5:37 AM

Oppenheimer analyst Matthew Biegler initiates coverage on Blueprint Medicines (NASDAQ:BPMC) with a Outperform rating and announces Price Target of $80.

BPMC

1 minute read

FDA
News

Blueprint Medicines Received FDA Orphan Drug Designation for Treatment of Mastocytosis

By Charles Gross

Today, 5:37 AM

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=890922

BPMC

1 minute read

SVB Leerink Maintains Market Perform on Blueprint Medicines, Lowers Price Target to $56

By Benzinga Newsdesk

Today, 5:37 AM

SVB Leerink analyst Andrew Berens maintains Blueprint Medicines (NASDAQ:BPMC) with a Market Perform and lowers the price target from $60 to $56.

BPMC

1 minute read

Wells Fargo Initiates Coverage On Blueprint Medicines with Underweight Rating, Announces Price Target of $40

By Benzinga Newsdesk

Today, 5:37 AM

Wells Fargo analyst Derek Archila initiates coverage on Blueprint Medicines (NASDAQ:BPMC) with a Underweight rating and announces Price Target of $40.

BPMC

2 minute read

Analyst Ratings

SVB Leerink Maintains Market Perform Rating for Blueprint Medicines: Here’s What You Need To Know

By Benzinga Insights

Today, 5:37 AM

SVB Leerink has decided to maintain its Market Perform rating of Blueprint Medicines (NASDAQ:BPMC) and lower its price target from $82.00 to $60.00. Shares of Blueprint Medicines are trading down 8.32% over the last 24 hours, at $44.07 per share.

BPMC

1 minute read

10 Biggest Price Target Changes For Monday

By Lisa Levin

Today, 5:37 AM

RBC Capital reduced Tesla, Inc. (NASDAQ: TSLA) price target from $1,175 to $1,100. Tesla shares fell 3.7% to $670.89 in pre-market trading.

BBBY

1 minute read

SVB Leerink Maintains Market Perform on Blueprint Medicines, Lowers Price Target to $60

By Benzinga Newsdesk

Today, 5:37 AM

SVB Leerink analyst Andrew Berens maintains Blueprint Medicines (NASDAQ:BPMC) with a Market Perform and lowers the price target from $82 to $60.

BPMC

6 minute read

91 Biggest Movers From Friday

By Lisa Levin

Today, 5:37 AM

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

ABVC

3 minute read

44 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 5:37 AM

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

AUVI

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 10, 2022

By Benzinga Insights

Today, 5:37 AM

ACVA